Loading...
Loading...
FBIOP| Name | Value |
|---|---|
| Revenues | 17.4M |
| Cost of Revenue | 7.8M |
| Gross Profit | 9.6M |
| Operating Expense | 56.6M |
| Operating I/L | -50.1M |
| Other Income/Expense | -9.2M |
| Interest Income | 0.7M |
| Pretax | -59.3M |
| Income Tax Expense | -28.9M |
| Net Income/Loss | -24.8M |
Fortress Biotech, Inc. is a biopharmaceutical company specializing in the development and commercialization of pharmaceutical and biotechnology products. The company's revenue is generated through the marketing of dermatology products, including treatments for acne, ringworm, dry skin conditions, wound management, and severe recalcitrant nodular acne. Additionally, it focuses on late-stage product candidates for various medical conditions such as post-operative acute pain, Menkes disease, severe combined immunodeficiency, metastatic cancers, and other targeted treatments. The company also has a pipeline of early-stage and preclinical product candidates, as well as collaboration arrangements with universities, research institutes, and pharmaceutical companies.
